Ling Tong

Title: Ling Tong: Innovator in Pharmaceutical Crystallization

Introduction

Ling Tong is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new crystalline forms of drugs. With a total of 2 patents, his work focuses on enhancing the stability and purity of pharmaceutical compounds.

Latest Patents

Ling Tong's latest patents include the invention of a new crystalline form VII of agomelatine, along with its preparation method and applications. This innovative crystalline form offers high purity, a stable crystalline structure, and good reproducibility. The method of production is well-suited for large-scale manufacturing, making it advantageous for pharmaceutical preparations. Additionally, he has developed crystals of prasugrel hydrobromate, which exhibit excellent stability and solubility, further contributing to the field of drug formulation.

Career Highlights

Throughout his career, Ling Tong has worked with prominent organizations such as the Shanghai Institute of Pharmaceutical Industry and Les Laboratoires Servier. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Ling Tong has collaborated with several professionals in the field, including Zhedong Yuan and Xiong Yu. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Ling Tong's contributions to pharmaceutical crystallization demonstrate his commitment to innovation in drug development. His work not only enhances the quality of pharmaceutical products but also paves the way for future advancements in the industry.